ABSTRACT BACKGROUND: Superficially invasive neoplasias of the uterine cervix are a matter of controversy in terms of their definition, prognostic factors and selection of treatment to minimize the risk of recurrences. METHODS: Forty-three women with invasive cervical carcinoma, operated from 1993 to 2003, were postoperatively staged as IA cervical carcinoma. There were 28 patients who were submitted to class III radical hysterectomy, 9 patients to class II hysterectomy, 2 patients to class I hysterectomy, and 2 patients to abdominal trachelectomy and pelvic lymph node dissection. Mean age of patients was 44 years (range, 27-64 years). RESULTS: Twenty-three patients (56.1%) were stage with IA 1 and 18 (43.9%) with stage IA 2 disease according to the 1995 FIGO classification. Tumor histology revealed squamous cell carcinoma in 38 (92.6%) cases, adenocarcinoma in 2 (4.8%) cases and glassy cell carcinoma in 1 (2.4%). The average number of examined lymph nodes was 17.4 (2-53). Lymphovascular space invasion was identified in 3 patients. None of the 41 patients had metastasis to the pelvic lymph nodes or developed recurrence of disease.
INTRODUCTION
C ervical carcinoma is the commonest gynecological cancer and is in the second place among women with malignant diseases in Vojvodina (9.4%). Despite the availability of Pap smear screening, almost 324 women in Vojvodina will be diagnosed with invasive cervical cancer each year and nearly 146 women will die of cervical cancer each year (1) .
Microinvasive carcinoma of the cervix is an invasive lesion identified only microscopically.
All greater tumors even with superficial invasion are stage IB cancers according to 1995 FIGO classification. Mean age of patients is 40 years. The disease is asymptomatic, usually found during investigation for abnormal Pap smear. Cervix often appears normal on routine pelvic exam. The diagnosis can be made only by means of a thoroughly examined conization specimen. With recurrence rates in these two substages, which are no more than 1% to 2%, it has excellent prognosis. Survival of stage IA1 can approach 99% and stage IA2 can approach 97%-98% (2).
PATIENTS AND METHODS
This retrospective study was performed in the Institute of Oncology in Sremska Kamenica between 1993 and 2003. We analyzed the data from patients' histories of 41 women with invasive cervical carcinoma, who underwent to radical hysterectomy and lymphadenectomy and were postoperatively staged as IA cervical carcinoma. Histopatholgical examination of cervical biopsy and/or cervical curettement revealed invasive cervical carcinoma, preoperatively staged as IB1. There were 28 patients who were submitted to class III radical hysterectomy, 9 patients to class II hysterectomy, 2 patients to class I hysterectomy, and 2 patients to abdominal trachelectomy and pelvic lymph node dissection. Mean age of patients was 44 years (range, 27-64 years).
RESULTS
A total of 41 patients were followed from 1 to 10 years with a median follow-up interval of 4.6 years. There were 23 (56.1%) patients with early stromal invasion (IA1) and 18 (43.9%) with microinvasive carcinoma (IA2) according to FIGO criteria (1995) . Tumor histology revealed squamous cell carcinoma in 38 (92.6%) cases, adenocarcinoma in 2 (4.8%) cases, and glassy cell carcinoma in 1 (2.4%).
Seven patients were submitted to conization, but for all of them treatment was completed with radical hysterectomy and pelvic lymph node dissection due to diagnosis of stage IA2 In 82 patients with 3 mm or less depth of invasion Takeshima found the incidence of lymph node metastasis in 1.2%. The incidence of lymph node metastasis was 3.4% in patients with 3 to 5 mm depth of invasion. None of the patients in this series had metastasis to the parametrial tissues (8) .
Patients with carcinoma where depth of invasion extends to 5 mm have increased risk of lymphovascular space involvement and metastatic disease. The pelvic node metastasis rates lie between 3 and 5% (2). In Burghardt's review of 409 patients with microinvasive carcinoma 7 (1.7%) patients developed fatal recurrences (9) . So, the therapy of microinvasive cervical cancer (stage IA 1 and IA 2 ) depends on the presence of significant prognostic factors and must be individualized. It depends on depth of invasion, superficial spread of lesion, lymphovascular space infiltration, poor differentiation, confluent pattern of invasion, lymph node involvement and positive cone margins (10).
Exact work-up of the cone is the basis for successful treatment.
Patients with cervical cancer stage IA 1 have an extremely low risk of pelvic lymph node metastases and they can be treated safely with cervical conization, or simple hysterectomy (11) . Every histologic criteria of this definition must be met and all conization margins must be free of dysplasia or invasive disease. Patients must be reliable so that they can be fol- Oral lichen planus (OLP) is one of the most prevalent oral mucosal lesions with an increased potential for malignant development (6) . Because of the variations in appearance, the diagnosis of OLP should not be assessed on the histopathologic picture alone, but should also be based on distinct clinical criteria. Histopathologically, typical OLP in a substantial percentage does not correlate with a typical clinical appearance (7).
The management of PMOL is problematical and is largely dependent on the collection of both clinical and histopathologic information.
The aim of the present study was to determine the correlation between clinical and histopathologic diagnoses of PMOL using the discrepancy index. actinic cheilitis were determined to be potentially malignant lesions. The clinical diagnosis was reached according to the criteria described in Table 1 .
PATIENTS AND METHODS

The
Histopathologic examination of all lesions was performed. If the lesions were small, an excisional biopsy was usually performed. For the large lesions, an incisional biopsy was performed and multiple specimens from different areas were taken. The biopsy specimens
